BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 37639817)

  • 1. Triggering of ovulation for GnRH-antagonist cycles in normal and low ovarian responders undergoing IVF/ICSI: A systematic review and meta-analysis of randomized trials.
    He FF; Hu W; Yong L; Li YM
    Eur J Obstet Gynecol Reprod Biol; 2023 Oct; 289():65-73. PubMed ID: 37639817
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gonadotropin-releasing hormone agonist versus HCG for oocyte triggering in antagonist-assisted reproductive technology.
    Youssef MA; Van der Veen F; Al-Inany HG; Mochtar MH; Griesinger G; Nagi Mohesen M; Aboulfoutouh I; van Wely M
    Cochrane Database Syst Rev; 2014 Oct; 2014(10):CD008046. PubMed ID: 25358904
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dual trigger with the combination of gonadotropin-releasing hormone agonist and standard dose of human chorionic gonadotropin improves
    Mutlu I; Demirdag E; Cevher F; Erdem A; Erdem M
    J Obstet Gynaecol; 2022 Jul; 42(5):1239-1244. PubMed ID: 34565274
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Conventional GnRH antagonist protocols versus long GnRH agonist protocol in IVF/ICSI cycles of polycystic ovary syndrome women: a systematic review and meta-analysis.
    Kadoura S; Alhalabi M; Nattouf AH
    Sci Rep; 2022 Mar; 12(1):4456. PubMed ID: 35292717
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative study between single versus dual trigger for poor responders in GnRH-antagonist ICSI cycles: A randomized controlled study.
    Maged AM; Ragab MA; Shohayeb A; Saber W; Ekladious S; Hussein EA; El-Mazny A; Hany A
    Int J Gynaecol Obstet; 2021 Mar; 152(3):395-400. PubMed ID: 33011968
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ovulation triggering with hCG alone, GnRH agonist alone or in combination? A randomized controlled trial in advanced-age women undergoing IVF/ICSI cycles.
    Zhou C; Yang X; Wang Y; Xi J; Pan H; Wang M; Zhou Y; Xiao Y
    Hum Reprod; 2022 Jul; 37(8):1795-1805. PubMed ID: 35595223
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gonadotropin-releasing hormone agonist versus HCG for oocyte triggering in antagonist assisted reproductive technology cycles.
    Youssef MA; Van der Veen F; Al-Inany HG; Griesinger G; Mochtar MH; Aboulfoutouh I; Khattab SM; van Wely M
    Cochrane Database Syst Rev; 2011 Jan; (1):CD008046. PubMed ID: 21249699
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dual trigger of final oocyte maturation with a combination of GnRH agonist and hCG versus a hCG alone trigger in GnRH antagonist cycle for in vitro fertilization: A Systematic Review and Meta-analysis.
    Ding N; Liu X; Jian Q; Liang Z; Wang F
    Eur J Obstet Gynecol Reprod Biol; 2017 Nov; 218():92-98. PubMed ID: 28957685
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gonadotropin-releasing hormone agonist versus HCG for oocyte triggering in antagonist assisted reproductive technology cycles.
    Youssef MA; Van der Veen F; Al-Inany HG; Griesinger G; Mochtar MH; van Wely M
    Cochrane Database Syst Rev; 2010 Nov; (11):CD008046. PubMed ID: 21069701
    [TBL] [Abstract][Full Text] [Related]  

  • 10. GnRH Agonist and hCG (Dual Trigger) Versus hCG Trigger for Final Oocyte Maturation in Expected Normal Responders With a High Immature Oocyte Rate: Study Protocol for a Randomized, Superiority, Parallel Group, Controlled Trial.
    Yan MH; Cao JX; Hou JW; Jiang WJ; Wang DD; Sun ZG; Song JY
    Front Endocrinol (Lausanne); 2022; 13():831859. PubMed ID: 35418945
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dual trigger with combination of gonadotropin-releasing hormone agonist and human chorionic gonadotropin significantly improves the live-birth rate for normal responders in GnRH-antagonist cycles.
    Lin MH; Wu FS; Lee RK; Li SH; Lin SY; Hwu YM
    Fertil Steril; 2013 Nov; 100(5):1296-302. PubMed ID: 23993928
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dual triggering with GnRH agonist plus hCG versus triggering with hCG alone for IVF/ICSI outcome in GnRH antagonist cycles: a systematic review and meta-analysis.
    Chen CH; Tzeng CR; Wang PH; Liu WM; Chang HY; Chen HH; Chen CH
    Arch Gynecol Obstet; 2018 Jul; 298(1):17-26. PubMed ID: 29600322
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dual trigger using recombinant HCG and gonadotropin-releasing hormone agonist improve oocyte maturity and embryo grading for normal responders in GnRH antagonist cycles: Randomized controlled trial.
    Ali SS; Elsenosy E; Sayed GH; Farghaly TA; Youssef AA; Badran E; Abbas AM; Abdelaleem AA
    J Gynecol Obstet Hum Reprod; 2020 May; 49(5):101728. PubMed ID: 32173633
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of Dual Trigger with Combination of Gonadotropin-Releasing Hormone Agonist and Human Chorionic Gonadotropin in İmproving Oocyte-Follicle Ratio in Normo-Responder Patients.
    Gurbuz AS; Deveer R; Gode F
    Niger J Clin Pract; 2021 Aug; 24(8):1159-1163. PubMed ID: 34397024
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of Dual Trigger In Vitro Fertilization and Intracytoplasmic Sperm Injection During the Gonadotropin-releasing Hormone-Antagonist Cycle on Final Oocyte Maturation and Cumulative Live Birth Rate in Women with Diminished Ovarian Reserve.
    Ren YM; Wang YB; Fu M; Zhang QX; Shen H; Han HJ; Gao FM
    Curr Med Sci; 2022 Oct; 42(5):1066-1070. PubMed ID: 35997911
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of dual trigger with combination GnRH agonist and hCG versus hCG alone trigger of oocyte maturation for normal ovarian responders.
    Zhou X; Guo P; Chen X; Ye D; Liu Y; Chen S
    Int J Gynaecol Obstet; 2018 Jun; 141(3):327-331. PubMed ID: 29388691
    [TBL] [Abstract][Full Text] [Related]  

  • 17. GnRH agonist versus HCG triggering in different IVF/ICSI cycles of same patients: a retrospective study.
    Yılmaz N; Ceran MU; Ugurlu EN; Gülerman HC; Engin Ustun Y
    J Obstet Gynaecol; 2020 Aug; 40(6):837-842. PubMed ID: 31791167
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dual trigger improves the pregnancy rate in fresh in vitro fertilization (IVF) cycles compared with the human chorionic gonadotropin (hCG) trigger: a systematic review and meta-analysis of randomized trials.
    Hsia LH; Lee TH; Lin YH; Huang YY; Chang HJ; Liu YL
    J Assist Reprod Genet; 2023 Sep; 40(9):2063-2077. PubMed ID: 37466846
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reproductive outcomes of dual trigger with combination GnRH agonist and hCG versus trigger with hCG alone in women undergoing IVF/ICSI cycles: a retrospective cohort study with propensity score matching.
    Dong L; Lian F; Wu H; Xiang S; Li Y; Wei C; Yu X; Xin X
    BMC Pregnancy Childbirth; 2022 Jul; 22(1):583. PubMed ID: 35869444
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Early Follicular Phase Human Chorionic Gonadotropin Addition May Improve the Outcomes of
    Zhang C; Wu F; Wu Z; Sun B; Chen C; Qian W
    Front Endocrinol (Lausanne); 2021; 12():739773. PubMed ID: 34707571
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.